Soliciting or Advertising the Sale of Medicare Advantage Plans, Medicare Advantage Prescription Drug Plans, Prescription Drug Plans, and Section 1876 Cost Plans

Bulletin 13-16 Date: May 23, 2013 To: All Licensed Insurance Producers Re: Soliciting or advertising the sale of Medicare Advantage Plans, Medicare Advantage Prescription Drug Plans, Prescription Drug Plans, and Section 1876 Cost Plans The purpose of this bulletin is to remind all licensed insurance producers soliciting or advertising the sale of Medicare Advantage Plans, Medicare Advantage Prescription Drug Plans, Prescription Drug Plans, and Section 1876 Cost Plans that they are required to comply with all provisions of the Medicare Marketing Guidelines (Rev. 97, Issued 6-7-12 or any subsequent revision), issued pursuant to 42 CFR 422, 423 and 417, including but not limited to the following prohibitions: 1. Door-to-door solicitation, including leaving information such as a leaflet or flyer at a residence or car; 2. Approaching beneficiaries on common areas, (e.g. parking lots, hallways, lobbies, sidewalks, etc.); 3. Telephonic or electronic solicitation, including leaving electronic voicemail messages or text messaging. Failure to comply with these guidelines may subject the producer to action pursuant to Section 10-126 of the Insurance Article. Questions concerning this Bulletin may be directed to William Donahue, Assistant Chief Enforcement Officer, at 410-468-2347 or william.donahue@maryland.gov. Therese M. Goldsmith Commissioner By: _____________________________ Joy Hatchette, Associate Commissioner Consumer Education & Advocacy THERESE M. GOLDSMITH Commissioner KAREN STAKEM HORNIG Deputy Commissioner MARTIN O’MALLEY Governor ANTHONY G. BROWN Lt. Governor 200 St. Paul Place, Suite 2700 Baltimore, Maryland 21202 Direct Dial: 410-468-2020 Fax: 410-468-2020 1-800-492-6116 TTY: 1-800-735-2258 www.mdinsurance.state.md.us